We are live on ! Find out more
BPBT

Boston Private Bank & Trust Portfolio holdings

AUM $2.17B
1-Year Est. Return 12.34%
This Fund
S&P 500
This Quarter Est. Return
+1.31%
1 Year Est. Return
+12.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.97B
AUM Growth
-$31.9M
Cap. Flow
-$48.3M
Cap. Flow %
-2.45%
Top 10 Hldgs %
17.05%
Holding
1,119
New
62
Increased
266
Reduced
316
Closed
100

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$5.12M
2
MA icon
Mastercard
MA
+$4.2M
3
CVS icon
CVS Health
CVS
+$3.58M
4
CB icon
Chubb
CB
+$2.89M
5
ABT icon
Abbott
ABT
+$2.59M

Sector Composition

Rank Sector Weight
1 Healthcare 16.33%
2 Technology 13.01%
3 Industrials 11.43%
4 Energy 10.67%
5 Financials 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXY icon
26
Occidental Petroleum
OXY
$56.8B
$18.9M 0.96%
207,243
+9,389
+5% +$839K
CAH icon
27
Cardinal Health
CAH
$53.9B
$18.6M 0.94%
265,406
-10,784
-4% -$750K
VLO icon
28
Valero Energy
VLO
$90.1B
$18.3M 0.93%
344,277
-17,887
-5% -$916K
PX
29
DELISTED
Praxair Inc
PX
$18.3M 0.93%
139,534
-4,969
-3% -$644K
CVS icon
30
CVS Health
CVS
$133B
$18.1M 0.92%
242,035
+50,741
+27% +$3.58M
IBM icon
31
IBM
IBM
$211B
$17.6M 0.89%
95,683
-34,075
-26% -$6M
GILD icon
32
Gilead Sciences
GILD
$162B
$17M 0.86%
239,521
-3,310
-1% -$260K
KRFT
33
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$16.6M 0.84%
296,219
+2,171
+0.7% +$118K
NVS icon
34
Novartis
NVS
$297B
$16.6M 0.84%
218,098
+2,286
+1% +$167K
TJX icon
35
TJX Companies
TJX
$174B
$16.5M 0.84%
543,350
+2,822
+0.5% +$85.4K
CB
36
DELISTED
CHUBB CORPORATION
CB
$16.3M 0.82%
182,068
-28,978
-14% -$2.54M
DIS icon
37
Walt Disney
DIS
$167B
$15.8M 0.8%
197,166
-510
-0.3% -$39.5K
QCOM icon
38
Qualcomm
QCOM
$155B
$15.3M 0.77%
193,443
-597
-0.3% -$45K
BMY icon
39
Bristol-Myers Squibb
BMY
$133B
$15M 0.76%
288,126
-13,356
-4% -$711K
ABT icon
40
Abbott
ABT
$183B
$14.9M 0.76%
388,018
+67,262
+21% +$2.59M
IWV icon
41
iShares Russell 3000 ETF
IWV
$19.6B
$14.5M 0.73%
128,998
-1,200
-0.9% -$132K
ABBV icon
42
AbbVie
ABBV
$443B
$14.5M 0.73%
281,514
-2,118
-0.7% -$107K
KO icon
43
Coca-Cola
KO
$377B
$14M 0.71%
363,187
-41,671
-10% -$1.61M
EMC
44
DELISTED
EMC CORPORATION
EMC
$13.8M 0.7%
505,175
-21,540
-4% -$560K
NKE icon
45
Nike
NKE
$61.9B
$13.8M 0.7%
373,602
+868
+0.2% +$32.8K
ORCL icon
46
Oracle
ORCL
$374B
$13.8M 0.7%
336,483
-29,229
-8% -$1.11M
VTI icon
47
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$13.6M 0.69%
139,640
-3,005
-2% -$288K
MDT icon
48
Medtronic
MDT
$109B
$13.5M 0.68%
219,502
-40,032
-15% -$2.33M
SBUX icon
49
Starbucks
SBUX
$120B
$13.4M 0.68%
363,996
+11,864
+3% +$439K
PEP icon
50
PepsiCo
PEP
$190B
$13.3M 0.67%
159,095
-237
-0.1% -$19.2K

Similar funds

Boston Private Bank & Trust's Q1 2014 Portfolio in Review

As of Q1 2014, Boston Private Bank & Trust held 1,119 positions worth $1.97B, down 1.6% from $2.01B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Private Bank & Trust's Q1 2014 filing shows 62 new, 266 increased, 316 reduced and 100 closed positions. Its largest new stake was Alkermes: 13,000 shares worth $573K. The largest sale was Schwab International Small-Cap Equity ETF, an estimated $14.9M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Boston Private Bank & Trust's largest Q1 2014 buy was Alkermes: 13,000 shares worth $573K.
  • Boston Private Bank & Trust added most to Procter & Gamble in Q1 2014, an estimated $5.12M increase.
  • Boston Private Bank & Trust's biggest Q1 2014 reduction was Schwab International Small-Cap Equity ETF, cutting an estimated $14.9M.
  • Boston Private Bank & Trust fully exited Itaú Unibanco in Q1 2014, selling an estimated $806K.
  • Boston Private Bank & Trust's ten largest holdings make up 17% of its $1.97B portfolio in Q1 2014.
  • Boston Private Bank & Trust opened 62 new positions and closed 100 in Q1 2014.
  • Boston Private Bank & Trust's portfolio value fell 1.6% quarter-over-quarter to $1.97B.

Based on Boston Private Bank & Trust's 13F filing for Q1 2014, filed 15 Apr 2014.